CLINICAL_TRIALS
trial_result
· 2018-04-27
Clinical Trial Update: A Study of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes Mellitus [Phase 3]
Summary
A Phase 3 clinical trial update for dulaglutide (LY2189265) in participants with Type 2 Diabetes Mellitus has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Type 2 Diabetes Mellitus | Phase 3 | Status: COMPLETED | Results posted: 2018-04-27